RxDoctor Payments Data

John Harris, MD

Family Medicine · Ringgold, GANPI 1871518860

Payments from drug & device makers

$5,222in general payments, 2019–2025

Across 296 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$561
  • GSK$507
  • Novo Nordisk$372
  • Pfizer$312
  • Amgen$306
  • Sanofi-aventis U.S. LLC$294
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$5,16399%
  • Gifts$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,222 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$93,058
Medicare patients
265
Services billed
4,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter127$125,339
MounjaroTirzepatide72$80,038
JardianceEmpagliflozin76$75,627
XareltoRivaroxaban65$70,078
EliquisApixaban72$57,926
TrulicityDulaglutide45$57,846
OzempicSemaglutide54$55,104
LinzessLinaclotide39$46,494
Soliqua 100-33Insulin Glargine/Lixisenatide29$37,316
VraylarCariprazine Hcl17$34,440
Janumet XrSitagliptin Phos/Metformin Hcl28$33,530
JanuviaSitagliptin Phosphate47$32,877
FarxigaDapagliflozin Propanediol46$30,619
Repatha SureclickEvolocumab40$30,088
MyrbetriqMirabegron27$20,819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$507$150,032159 claims
Lilly USA, LLCMounjaro, Trulicity$249$137,884117 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Synjardy Xr$179$120,800127 claims
AbbVieLinzess, Vraylar, Synthroid$561$85,573120 claims
Johnson & JohnsonXarelto$80$70,07865 claims
PfizerEliquis, Abrysvo$312$68,355107 claims
MerckJanumet Xr, Januvia$113$66,40675 claims
Novo NordiskOzempic, Fiasp$372$64,05168 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$294$37,31629 claims
AstraZenecaFarxiga$250$30,61946 claims
NovartisEntresto$104$8,84313 claims
Esperion Therapeutics, Inc.Nexlizet$67$5,57812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Ringgold

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →